International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Psychoactive Substances: Overview of their identification techniques

Author Affiliations

  • 1Department of Applied Chemistry, Delhi Technological University, Delhi – 110042, India

Res. J. Recent Sci., Volume 12, Issue (2), Pages 40-51, July,2 (2023)

Abstract

The rapidly increasing trend of the use of psychoactive substances among youth is alarming. The lack of awareness about their harmful health effects leads to their misuse. Hence, their manufacture, possession, and use are kept under control by the Government. Fast identification and quantification of these substances are of paramount importance. The methods like HPTLC and HPLC have been extensively used for their analysis and quantification. This review article covers the basics of psychoactive substances, their addictions, regulations, analysis, and identification with the help of HPTLC and HPLC.

References

  1. Matson, J.L. and Neal D. (2009)., Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview., Res. Dev. Disabil., 30(3), 572-586. https://doi.org/10.1016/j.ridd.2008.08.007
  2. Northern Territory Department of Health (2005)., Chapter 1: Alcohol and Other Drugs., The Public Health Bush Book Volume 2: Facts & approaches to three key public health issues, Northern Territory Department of Health. ISBN: 978-0-724-533619
  3. Withington Phil (2014)., Introduction: Cultures of Intoxication., In P. Withington, A. McShane (ed.), Cultures of Intoxication: Past and Present (suppl 9), Oxford University Press, pp 9-33, ISBN: 978-0-198-71562-7.
  4. Withington Phil & McShane Angela (2014)., Cultures of Intoxication: Past and Present., Oxford University Press. ISBN: 978-0-198-71562-7
  5. Thakker Jo (2013)., International perspectives on addiction., In Miller, P. (Ed.) Principles of Addiction: Comprehensive Addictive Behaviors and Disorders volume 1, Academic Press, pp 51-59, ISBN: 978-0-123-98336-7.
  6. Shortall Sarah (2014)., Psychedelic drugs and the problem of experience., In P. Withington, A. McShane (Ed.), Cultures of Intoxication: Past and Present (suppl 9), Oxford University Press, 187-206, ISBN: 978-0-198-71562-7.
  7. Merlin, M.D. (2003)., Archaeological evidence for the tradition of psychoactive plant use in the old world., Econ. Bot., 57, 295-323. https://doi.org/10.1663/0013-0001 (2003)057[0295: AEFTTO]2.0.CO;2
  8. Dillehay, T.D., Rossen, J., Ugent, D., Karathanasis, A., Vásquez, V., & Netherly, P.J. (2010)., Early Holocene coca chewing in northern Peru., Antiquity, 84(326), 939-953. https://doi.org/10.1017/S0003598X00067004
  9. Palmer, J. (2010)., Coca leaves first chewed 8,000 years ago, says research., BBC News, 2. https://www.bbc.com/news/science-environment-118782 41. (Accessed in sep 2022)
  10. Siegel, R. K. (2005)., Intoxication: The universal drive for mind-altering substances., Inner Traditions/Bear & Co.
  11. Weil Andrew (2004)., The Natural Mind: A Revolutionary Approach to the Drug Problem., Houghton Mifflin Company, pp 14-32, ISBN: 978-0-618-46513-2
  12. Ludlow Fitz Hugh (1857)., The Hasheesh Eater., Harper and Brothers Publishers, ISBN 978-1-515-02748-5
  13. UNO (1972)., United Nations Conference to consider amendments to the Single Convention on Narcotic Drugs, 1961, United Nations Office, Geneva, 6-24 March 1972., undefined
  14. 91st United States Congress (1970)., Part F—Advisory Commission: Establishment of Commission on Marihuana and Drug Abuse., U.S. Government Publishing Office, 1280-1281, 1970.
  15. MacCoun, R. and Reuter, P. (1997)., Interpreting Dutch Cannabis Policy: Reasoning by Analogy in the Legalization Debate. Science, 278(5335), 47-52. https://doi.org/10.1126 /science.278.5335.47, undefined
  16. Temple Robert (1994)., Principles of Pharmacy., pp 1643.
  17. Weis Serge, Sonnberger Michael, Dunzinger Andreas, Voglmayr Eva, Aichholzer Martin, Kleiser Raimund & Strasser Peter (2019)., Intoxication: Street Drugs., In: Imaging Brain Diseases, Springer, pp 1243-1260. ISBN: 978-3-709-11543-5
  18. Soyka, M. (2017)., Treatment of Benzodiazepine Dependence., N. Engl. J. Med., 376, 1147-1157. https://doi.org/10.1056/NEJMra1611832
  19. Volkow, N.D. and McLellan, A.T. (2016)., Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies., N. Engl. J. Med., 374, 1253-1263. https://doi.org/10.1056/NEJMra1507771
  20. Nichols, D.E. (2016)., Psychedelics., Pharmacol. Rev., 68(2), 264-355. https://doi.org/10.1124/pr.115.011478
  21. Lafaye, G., Karila, L., Blecha, L., & Benyamina, A. (2017)., Cannabis, cannabinoids, and health., Dialogues Clin. Neurosci., 19(3), 309-316. https://doi.org/10.31887/DCNS. 2017.19.3/glafaye
  22. Weinberg, D. (2011)., Sociological Perspectives on Addiction., Sociol. Compass., 5(4), 298-310. https://doi.org/10.1111/j.1751-9020.2011.00363.x
  23. Westermeyer Joseph (2013)., Historical understandings of addiction., In Miller, P. (Ed.) Principles of Addiction: Comprehensive Addictive Behaviors and Disorders, Volume 1, Academic Press, pp 3-12. ISBN: 978-0-123-98336-7
  24. Bardo, M.T., Neisewander, J.L., & Kelly, T.H. (2013)., Individual differences and social influences on the neurobehavioral pharmacology of abused drugs., Pharmacol. Rev., 65(1), 255-290. https://doi.org/10.1124 /pr.111.005124
  25. Blum, K., Chen, A.L., Giordano, J., Borsten, J., Chen, T.J., Hauser, M., Simpatico, T., Femino, J., Braverman, E.R., & Barh, D. (2012)., The Addictive Brain: All Roads Lead to Dopamine., J. Psychoact. Drugs, 44(2), 134-143. https://doi.org/10.1080/02791072.2012.685407
  26. Bickel, W.K. and Marsch, L.A. (2001)., Toward a behavioral economic understanding of drug dependence: delay discounting processes., Addiction, 96(1), 73-86. https://doi.org/10.1046/j.1360-0443.2001.961736.x
  27. Cameron, D., & Jones, I. G. (1985)., An epidemiological and sociological analysis of the use of alcohol, tobacco and other drugs of solace., Journal of Public Health, 7(1), 18-29.
  28. Courtwright, David T. (2002)., Forces of habit: Drugs and the making of the Modern World., Harvard University Press. ISBN 978-0-674-01003-1
  29. Crocq, M.A. (2007)., Historical and clinical aspects of man’s relationship with addictive drugs., Dialogues Clin. Neurosci., 9(4), 355-361. https://doi.org/10.31887/DCNS. 2007.9.4/macrocq
  30. Miller, P. M. (2013)., Principles of addiction: Comprehensive addictive behaviors and disorders., Vol. 1. Academic Press.
  31. Gowing, L.R., Ali, R.L., Allsop, S., Marsden, J., Turf, E.E., West, R., & Witton, J. (2015)., Global statistics on addictive behaviours: 2014 status report., Addiction, 110(6), 904-919. https://doi.org/10.1111/add.12899
  32. United Nations Office on Drugs and Crime (2018)., World Drug Report 2018: Executive summary conclusions and policy implications (United Nations publication, Sales No. E. 18. XI. 9).,
  33. World Health Organization (2021)., Substance abuse facts psychoactives., https://www.who.int/substance_abuse/facts /psychoactives/en/. Retrieved on 12/09/2021.
  34. Bone, K., (1991)., Turmeric - The spice of life?., Br. J. Phytotherapy, 2, 51-60.
  35. Dubey, R.C., Rana, A., & Shukla, R.K. (2005)., Antibacterial activity of essential oils of some medicinal plants against certain human pathogens., Indian Drugs, 42(7), 443-446.
  36. Kaushik, P., & Dhiman, A. K. (1999)., Medicinal plants and raw drugs of India., Bishen Singh Mahendra Pal Singh.
  37. Shastri, B.N. (1952)., The wealth of India- Raw materials., III, Publications and Information Directorate, CSIR, New Delhi, 168, 1952.
  38. Wolff, K., Farrell, M., Marsden, J., Monteiro, M.G., Ali, R., Welch, S., & Strang, J. (1999)., A review of biological indicators of illicit drug use, practical considerations and clinical usefulness., Addiction, 94(9), 1279-1298. https://doi.org/10.1046/j.1360-0443.1999.94912792.x
  39. Morgan, C.J.A., Noronha, L.A, Muetzelfeldt, M., Fielding, A., & Curran, H.V. (2013)., Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users., J. Psychopharmacol., 27(6), 497-506. https://doi.org/10.1177/0269881113477744
  40. Siddiqui, M.R., AlOthman, Z.A., & Rahman, N. (2017)., Analytical techniques in pharmaceutical analysis: A review., Arab. J. Chem., 10(suppl_1), S1409-S1421. https://doi.org/10.1016/j.arabjc.2013.04.016
  41. Abdulrahman, S.A.M. and Basavaiah, K. (2011)., Non-aqueous titrimetric assay of gabapentin in capsules using perchloric acid as titrant., Chem. Ind. Chem. Eng. Q., 17, 173-178. https://doi.org/10.2298/CICEQ101011001A
  42. Ashour, A., Hegazy, M.A.M., Moustafa, A.A., Kelani, K.O., & Fattah, L.E.A. (2009)., Validated stability indicating TLC method for the determination of noscapine., Drug Test. Anal., 1(7), 327-338. https://doi.org/ 10.1002/dta.46
  43. Rahman, N., Khatoon, A., & Rahman, H. (2012)., Studies on the development of spectrophotometric method for the determination of haloperidol in pharmaceutical preparations., Quim. Nova, 35(2), 392-397. https://doi.org/10.1590/S0100-40422012000200028
  44. De Souza, C.F., Martins, R.K.S., Da Silva, A.R., DaCunha, A.L.M.C., & Aucélio, R.Q. (2013)., Determination of enrofloxacin by room-temperature phosphorimetry after solid phase extraction on an acrylic polymer sorbent., Spectrochim. Acta A. Mol. Biomol. Spectrosc., 100, 51-58. https://doi.org/10.1016/j.saa.2012.01.043
  45. Qian, C., Yuan,Y., He, X., Liu, J., Shao, Q., Wu, H., & Qiao, H. (2012)., A Sensitive HPLC-MS/MS Analysis of Dencichine in Rat Plasma and Its Application to Pharmacokinetics., Am. J. Anal. Chem., 3(8), 596-603. https://doi.org/10.4236/ajac.2012.38078.
  46. Patel, R.B., Shankar, M.B., Patel, M.R., & Bhatt, K.K. (2008)., Simultaneous Estimation of Acetylsalicylic Acid and Clopidogrel Bisulfate in Pure Powder and Tablet Formulations by High-Performance Column Liquid Chromatography and High-Performance Thin-Layer Chromatography., J. AOAC Int., 91(4), 750-755. https://doi.org/10.1093/jaoac/91.4.750
  47. Patel, R.B., Patel, M.R., Bhatt, K.K., & Patel, B.G. (2010)., HPTLC method development and validation: quantification of paliperidone in formulations and in vitro release study., Anal. Methods, 2(5), 525-531. https://doi.org/10.1039/B9AY00276F
  48. Patel, R.B., Patel, M.R., Shankar, M.B., & Bhatt, K.K. (2009)., Simultaneous determination of alprazolam and fluoxetine hydrochloride in tablet formulations by high-performance column liquid chromatography and high-performance thin-layer chromatography., J. AOAC Int., 92(4),1082-1088. https://doi.org/10.1093/jaoac/92.4.1082
  49. Patel, M.R., Patel, R.B., Parikh, J.R., & Patel, B.G. (2011)., HPTLC method for estimation of isotretinoin in topical formulations, equilibrium solubility screening, and in vitro permeation study.J. Liq. Chromatogr., R.T., 34(16), 1783-1799. https://doi.org/10.1080/10826076.2011.579218
  50. Patel, R.B., Patel, M.R., Bhatt,K.K., & Patel, B.G. (2010)., Development and Validation of HPTLC Method for Estimation of Carbamazepine in Formulations and Its In Vitro Release Study., Chromatogra. Res. Int., 2011, 684369. https://doi.org/10.4061/2011/684369
  51. Patel, R.B., Patel, M.R., Bhatt, K.K., & Patel, B.G. (2010)., Development and Validation of an HPTLC Method for Determination of Olanzapine in Formulations., J. AOAC Int., 93(3), 811-819. https://doi.org/10.1093/jaoac/93.3.811
  52. Rele, R.V. (2014)., Validation Method of Oxolamine Citrate from Bulk Drug and Pharmaceutical Formulation by High Performance Liquid Chromatography Method., Int. J. Pharm Tech. Res., 7(4), 549-553.
  53. Panigrahy, U.P. and Reddy, A.S.K. (2015)., A novel validated RP-HPLC-DAD method for the simultaneous estimation of Netupitant and Palonosetron in bulk and pharmaceutical dosage form with forced degradation studies., Int. J. Chem. Tech. Res., 8, 317-337.
  54. Shah, P. and Shah, R. (2015)., A stability-indicating RP-HPLC method development and validation for the related substances determination of Imatinib process impurities and their degradation products in tablet dosage form., Int. J. Chem. Tech. Res., 8, 128-146.
  55. Rizwan, S.H., Sastry,V.G. and Imad, Q. (2015)., Stability Indicating Method Development and Validation of Bosentan in Bulk Drug and Formulation by Rp-Hplc Method., Int. J. Chem. Tech. Res., 8, 569-579.
  56. Dangre, P., Sawale, V., Meshram, S. and Gunde, M. (2015)., Development and validation of RP-HPLC method for the Simultaneous Estimation of Eprosartan mesylate and chlorthalidone in Tablet Dosage Form., Int. J. Chem. Tech. Res., 8, 163-168.
  57. Rajananda, V., Nair, N.K., & Navaratnam, V. (1985)., An evaluation of TLC systems for opiate analysis., Bull. Narc., 37, 35-47.
  58. Ahadi, A., Partoazar, A., Abedi-Khorasgani, M.H., & Shetab-Boushehri, S.V. (2011)., Comparison of liquid-liquid extraction-thin layer chromatography with solid-phase extraction-high-performance thin layer chromatography in detection of urinary morphine., J. Biomed. Res., 25(5), 362-367. https://doi.org/10.1016/ S1674-8301(11)60048-1
  59. Szkutnik-Fiedler, D., Grześkowiak, E., Gaca, M., & Borowicz, M. (2011)., HPLC-UV determination of morphine in human plasma and its application to the clinical study., Acta. Pol. Pharm., 68(4), 473-479.
  60. Wada, M., Yokota, C., Ogata, Y., Kuroda, N., Yamada, H., & Nakashima, K. (2008)., Sensitive HPLC–fluorescence detection of morphine labeled with DIB-Cl in rat brain and blood microdialysates and its application to the preliminarily study of the pharmacokinetic interaction between morphine and diclofenac., Anal. Bioanal. Chem., 391(3), 1057-1062. https://doi.org/10.1007/s00216-008-2070-4
  61. Sharma, A., Gaurav, K., Singh, R., & Srivastava, R. (2017)., Development and Validation of a High-Performance Thin-Layer Chromatography—Densitometry Method for the Quantitative Estimation of Morphine in the Classical Ayurvedic Formulation Kamini Vidrawan Ras., JPC-J. Planar Chromat., 30(3), 188-192. https://doi.org/ 10.1556/1006.2017.30.3.6
  62. Sharma, A., Dhal, C., & Srivastava, R. (2019)., A comparative estimation of the morphine content of the ayurvedic formulation ‘Kamini Vidrawan Ras’ using validated high-performance thin-layer chromatography and high-performance liquid chromatography techniques., JPC-J. Planar Chromat., 32(1), 47–50. https://doi.org/10. 1556/1006.2019.32.1.6
  63. Berg, T., Lundanes, E., Christophersen, A.S., & Strand, D.H. (2009)., Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS/MS., J. Chromatogr. B, 877(4), 421-432. https://doi.org/10.1016/j.jchromb.2008.12.052.
  64. Johansen, S.S. and Bhatia, H.M. (2007)., Quantitative Analysis of Cocaine and Its Metabolites in Whole Blood and Urine By High-performance Liquid Chromatography Coupled With Tandem Mass Spectrometry., J. Chromatogr. B, 852(1-2), 338-344. https://doi.org/10. 1016/j.jchromb.2007.01.033
  65. Needham, S.R., Jeanville, P.M., Brown, P.R., &Estape, E.S. (2000)., Performance of a pentafluorophenylpropyl stationary phase for the electrospray ionization high-performance liquid chromatography–mass spectrometry–mass spectrometry assay of cocaine and its metabolite ecgonine methyl ester in human urine., J. Chromatogr. B, 748(1), 77-87. https://doi.org/10.1016/S0378-4347(00) 00271-1
  66. Bouzas, N.F., Dresen, S., Munz, B., & Weinmann, W. (2009)., Determination of basic drugs of abuse in human serum by online extraction and LC–MS/MS., Anal. Bioanal. Chem., 395(8), 2499. https://doi.org/10.1007/ s00216-009-3036-x
  67. Fernández, P., Morales, L., Vázquez, C., Bermejo, A.M., &Tabernero, M.J. (2006)., HPLC–DAD determination of opioids, cocaine and their metabolites in plasma., Forensic Sci. Int., 161(1), 31-35. https://doi.org/10.1016/j.forsciint. 2005.10.016
  68. López, P., Martello, S., Bermejo, A.M., De Vincenzi, E., Tabernero, M.J., & Chiarotti, M. (2010)., Validation of ELISA screening and LC–MS/MS confirmation methods for cocaine in hair after simple extraction., Anal. Bioanal. Chem., 397(4), 1539-1548. https://doi.org/10.1007/s00216-010-3684-x
  69. Mercolini, L., Mandrioli, R., Saladini, B., Conti, M., Baccini, C., & Raggi, M.A. (2008)., Quantitative analysis of cocaine in human hair by HPLC with fluorescence detection., J. Pharm. Biomed. Anal., 48(2), 456-461. https://doi.org/10.1016/j.jpba.2008.02.007
  70. Mortier, K.A., Maudens, K.E., Lambert, W.E., Clauwaert, K.M., Van Bocxlaer, J. F., Deforce, D.L., Van Peteghem, C.H., & De Leenheer, A.P. (2002)., Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry., J. Chromatogr. B, 779(2), 321-330. https://doi.org/10.1016/S1570-0232(02)00400-2
  71. Furugen, A., Nishimura, A., Kobayashi, M., Umazume, T., Narumi, K., & Iseki, K. (2019)., Quantification of eight benzodiazepines in human breastmilk and plasma by liquid-liquid extraction and liquid-chromatography tandem mass spectrometry: application to evaluation of alprazolam transfer into breastmilk., J. Pharm. Biomed. Anal., 168, 83-93. https://doi.org/10.1016/j.jpba.2019.02.011
  72. Melanson, S.E.F., Griggs, D., Bixho, I., Khaliq, T., & Flood, J.G. (2016)., 7-Aminoclonazepam is superior to clonazepam for detection of clonazepam use in oral fluid by LC–MS/MS., Clin. Chim. Acta, 455, 128-133. https://doi.org/10.1016/j.cca.2016.01.027
  73. Corcia, D.D., Lisi, S., Pirro, V., Gerace, E., Salomone, A., & Vincenti, M. (2013)., Determination of pharmaceutical and illicit drugs in oral fluid by ultra-high performance liquid chromatography–tandem mass spectrometry., J. Chromatogr. B, 927, 133-141. https://doi.org/10.1016/ j.jchromb.2013.01.025
  74. Samanidou,V., Kaltzi, I., Kabir, A., & Furton, K.G. (2016)., Simplifying sample preparation using fabric phase sorptive extraction technique for the determination of benzodiazepines in blood serum by high-performance liquid chromatography., Biomed.Chromatogr., 30(6), 829-836. https://doi.org/10.1002/bmc.3615
  75. Lee, H.H., Lee, J.F., Lin, S.Y., Lin, Y.Y., Wu, C.F., Wu, M.T., & Chen, B.H. (2013)., Simultaneous quantification of urine flunitrazepam, nimetazepam and nitrazepam by using liquid chromatography tandem mass spectrometry., Clin. Chim. Acta, 420, 134-139. https://doi.org/10.1016/j. cca.2012.10.023
  76. Perez, E.R., Knapp, J.A., Horn, C.K., Stillman, S.L., Evans, J.E., & Arfsten, D.P. (2016)., Comparison of LC–MS-MS and GC–MS analysis of benzodiazepine compounds included in the drug demand reduction urinalysis program., J. Anal. Toxico., 40(3), 201-207. https://doi.org/10.1093/ jat/bkv140
  77. Schaefer, N., Peters, B., Schmidt, P., & Ewald, A.H. (2013)., Development and validation of two LC-MS/MS methods for the detection and quantification of amphetamines, designer amphetamines, benzoylecgonine, benzodiazepines, opiates, and opioids in urine using turbulent flow chromatography., Anal. Bioanal. Chem., 405(1), 247-258. https://doi.org/10.1007/s00216-012-6458-9
  78. Moretti, M., Andrello, L., Visonà, S., Vignali, C., Groppi, A., Freni, F., Osculatia, L., Tajanaa, L., &Morini, L. (2018)., Evaluation of benzodiazepines and zolpidem in nails and their stability after prolonged exposure to chlorinated water., J. Pharm. Biomed. Anal., 152, 137-142. https://doi.org/10.1016/j.jpba.2018.01.051
  79. Lee, S., Han, E., In, S., Choi, H., Chung, H., & Chung, K.H. (2011)., Determination of illegally abused sedative-hypnotics in hair samples from drug offenders., J. Anal. Toxico., 35(5), 312-315. https://doi.org/10.1093/anatox/35. 5.312
  80. Kouser, S. and Reshma, H. (2014)., Method development and validation of simultaneous determination of Sertraline Hydrochlorde and Alprazolam in pharmaceutical dosage form by RP-HPLC., Pharm. sin., 5(6), 36-46.
  81. Adams, W.J., Bombardt, P.A., & Brewer, J.E. (1984)., Normal-phase liquid chromatographic determination of alprazolam in human serum., Anal. Chem., 56(9), 1590-1594. https://doi.org/10.1021/ac00273a012
  82. Patel, D.C., Patel, N.R., Sherikar, O.D., & Mehta, P.J. (2014)., Development and validation of RP-HPLC, HPTLC and UV-visible spectrophotometric methods for simultaneous estimation of alprazolam and propranolol hydrochloride in their combined dosage form., J. Anal. Chem., 69(7), 674-680. https://doi.org/10.1134/S1061934 814070119
  83. Pérez-Lozano, P., García-Montoya, E., Orriols, A., Miñarro, M., Ticó, J.R., & Suñé-Negre, J.M. (2004)., Development and validation of a new HPLC analytical method for the determination of alprazolam in tablets., J. Pharm. Biomed. Anal., 34(5), 979-987. https://doi.org/10. 1016/j.jpba.2003.12.012
  84. Shukla, S., Kumar, P., Moorthy, N.S.H.N., Shrivastava, S.K., Trivedi, P., & Srivastava, R.S. (2010)., RP-HPLC method development and its validation for simultaneous estimation of Alprazolam and Fluoxetine hydrochloride in pharmaceutical dosage form., Eurasian J. Anal. Chem., 5(3), 239-245.
  85. Patel, R.B., Patel, A.B., Patel, M.R., Shankar, M.B., & Bhatt, K.K. (2009)., Estimation of alprazolam and sertraline in pure powder and tablet formulations by high-performance liquid chromatography and high-performance thin-layer chromatography., Anal. Lett.,42(11), 1588-1602. https://doi.org/10.1080/00032710902994165
  86. Li, P., Han, H., Zhai, X., He, W., Sun, L., & Hou, J. (2012)., Simultaneous HPLC–UV determination of ketamine, xylazine, and midazolam in canine plasma., J. Chromatogr. Sci., 50(2), 108-113. https://doi.org/10.1093/ chromsci/bmr036
  87. Bolze, S. and Boulieu, R. (1998)., HPLC determination of ketamine, norketamine, and dehydronorketamine in plasma with a high-purity reversed-phase sorbent.Clin. Chem., 44(3), 560-564. https://doi.org/10.1093/clinchem/ 44.3.560, undefined
  88. Sultan, M. (2014)., Simultaneous HPLC determination and validation of amphetamine, methamphetamine, caffeine, paracetamol and theophylline in illicit seized tablets., Int. J. Pharm. Pharm. Sci., 6(4), 294-298.
  89. Pietraś, R., Skibiński, R., Komsta, Ł., Kowalczuk, D., & Panecka, E. (2010)., Validated HPTLC methods for quantification of mexiletine hydrochloride in a pharmaceutical formulation., J. AOAC Int., 93(3), 820-824. https://doi.org/10.1093/jaoac/93.3.820
  90. Patel, R.B., Patel, M.R., Bhatt, K.K., & Patel, B.G. (2010)., Development and validation of an HPTLC method for determination of olanzapine in formulations., J. AOAC Int., 93(3), 811-819. https://doi.org/10.1093/jaoac/93.3.811
  91. Anbazhagan, S., Indumathy, N., Shanmugapandiyan, P., & Sridhar, S.K. (2005)., Simultaneous quantification of stavudine, lamivudine and nevirapine by UV spectroscopy, reverse phase HPLC and HPTLC in tablets., J. Pharm. Biomed. Anal., 39(3-4), 801-804. https://doi.org/10.1016/ j.jpba.2005.04.044
  92. Rathore, A.S., Sathiyanarayanan, L., & Mahadik, K.R. (2010)., Development of Validated HPLC and HPTLC Methods for Simultaneous Determination of Levocetirizine Dihydrochloride and Montelukast Sodium in Bulk Drug and Pharmaceutical Dosage Form., Pharm. Anal. Acta, 1(1), 1000106. https://doi.org/10.4172/2153-2435.1000106.
  93. Shabir, G.A., Lough, W.J., Arain, S.A., & Bradshaw, T.K. (2007)., Evaluation and application of best practice in analytical method validation., J. Liq. Chromatogr. Relat. Technol., 30(3), 311-333. https://doi.org/10.1080/10826070 601084753
  94. Ferenczi-Fodor, K., Végh, Z., Nagy-Turák, A., Renger, B., & Zeller, M. (2001)., Validation and quality assurance of planar chromatographic procedures in pharmaceutical analysis., J. AOAC Int., 84(4), 1265-1276. https://doi.org/ 10.1093/jaoac/84.4.1265
  95. (ICH) Q2B (1997)., Validation of Analytical Procedures: Methodology., International Conference on Harmonization, Federal Register, 62(96), 27463-27467.
  96. CAMAG (2019)., Scientific Inc.. Camag planar chromatography catalog., http://www.camag. com. Retrieved on 01/04/2019
  97. Poole Collin F. (2000)., Chromatography., In I.D. Wilson (Ed.) Encyclopedia of Separation Science, Academic Press, pp 40-64. ISBN: 978-0-122-26770-3.
  98. Agbaba Danika & Sherma Joseph (2013)., Chromatographic Methods of Analysis: Thin Layer Chromatography., In J. Swarbrick (Ed.) Encyclopedia of Pharmaceutical Science and Technology, Six Volume Set (Print), CRC Press, 450-462. ISBN: 978-1-841-84819-8
  99. Sherma, J. (2010)., Review of HPTLC in Drug Analysis: 1996-2009., J. AOAC Int., 93(3), 754-764. https://doi.org/10.1093/jaoac/93.3.754
  100. Shewiyo, D.H., Kaale, E., Risha, P.G., Dejaegher, B., Smeyers-Verbeke, J., & Heyden, Y.V. (2012)., HPTLC methods to assay active ingredients in pharmaceutical formulations: A review of the method development and validation steps., J. Pharm. Biomed. Anal., 66, 11-23. https://doi.org/10.1016/j.jpba.2012.03.034
  101. Kasawar, G.B. and Farooqui, M. (2010)., Development and validation of a stability indicating RP-HPLC method for the simultaneous determination of related substances of albuterol sulfate and ipratropium bromide in nasal solution., J. Pharm. Biomed. Anal., 52(1), 19-29. https://doi.org/10.1016/j.jpba.2009.11.026
  102. Coskun, O. (2016). Separation techniques: Chromatography.North Clin. Istanb., 3(2), 156-160. https://doi.org/10.14744%2Fnci.2016.32757, undefined, undefined
  103. FDA (2000)., Guidance for Industry-Analytical Procedures and Method Validation, Chemistry, Manufacturing, and Controls Documentation., Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER), 2000.
  104. Lakshmi, R.P.S. (2015)., A Review on Chromatography with High Performance Liquid Chromatography (HPLC) and its Functions., Res. Rev. J. Pharma. Anal., 4(1), 1-15.
  105. Saibaba, S.V. and Pandiyan, P.S. (2016)., High Performance Thin Layer Chromatography: A Mini Review., Res. Pharm. Healt. Sci., 2(4), 219-226. https://doi.org/10.32463/rphs.2016.v02i04.43.